Comparison study of two commercially available methods for the determination of golimumab and anti-golimumab antibody levels in patients with rheumatic diseases

Clin Chem Lab Med. 2015 Oct;53(11):e297-9. doi: 10.1515/cclm-2015-0266.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / blood*
  • Antibodies, Monoclonal / immunology
  • Enzyme-Linked Immunosorbent Assay / standards*
  • Humans
  • Radioimmunoassay / standards*
  • Rheumatic Diseases / blood*
  • Rheumatic Diseases / immunology*

Substances

  • Antibodies, Monoclonal
  • golimumab